|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1243534972 |
| 003 |
OCoLC |
| 005 |
20231120010537.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
210327s2021 cau of 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OPELS
|d OCLCO
|d EBLCP
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|
| 019 |
|
|
|a 1242577697
|
| 020 |
|
|
|a 9780128219140
|
| 020 |
|
|
|a 0128219149
|
| 020 |
|
|
|z 9780128210130
|
| 020 |
|
|
|z 0128210133
|
| 035 |
|
|
|a (OCoLC)1243534972
|z (OCoLC)1242577697
|
| 050 |
|
4 |
|a R857.M3
|
| 082 |
0 |
4 |
|a 610.28
|2 23
|
| 245 |
0 |
0 |
|a Handbook on nanobiomaterials for therapeutics and diagnostic applications /
|c edited by Krishnan Anand [and more].
|
| 260 |
|
|
|a San Diego :
|b Elsevier,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (612 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro -- Handbook on Nanobiomaterials For Therapeutics and Diagnostic Applications -- Copyright -- Contents -- Contributors -- Chapter 1 Nanosomes for drug delivery -- 1.1 Introduction -- 1.2 Drug delivery system -- 1.3 Pharmacokinetics and pharmacodynamics -- 1.4 Types of nanosomes in drug delivery -- 1.4.1 Endosomes in drug delivery -- 1.4.2 Exosomes in drug delivery -- 1.4.3 Liposomes in drug delivery -- 1.4.4 siRNA-encapsulated nanosomes in drug delivery -- 1.4.4.1 Epidemiology -- 1.5 Nanosomes and gene therapy -- 1.6 Nanosome transportation mechanisms
|
| 505 |
8 |
|
|a 1.7 Blockades of nanosome trafficking -- 1.8 Drug release -- 1.9 Conclusion -- References -- Chapter 2 Nanomaterials for bioimaging studies -- 2.1 Introduction -- 2.2 Dye-loaded fluorescent silica nanoparticles (SiNPs) in bioimaging -- 2.2.1 Properties of SiNPs -- 2.2.2 Synthesis of SiNPs -- 2.2.3 Bioimaging -- 2.2.3.1 Typical fluorescent dye-doped SiNPs -- 2.2.3.2 Near-infrared fluorescent dye-doped SiNPs -- 2.2.3.3 Two-photon fluorescent dye silica nanoparticles -- 2.3 Imaging, targeting, and drug delivery using multifunctional inorganic nanoparticles (MiNPs)
|
| 505 |
8 |
|
|a 2.4 Lanthanide-doped upconverting nanoparticles -- 2.4.1 The fundamental mechanism of UCNPs -- 2.4.2 Synthesis of UCNPs -- 2.4.3 UCNPs as image contrasting agents -- 2.5 Conclusions -- References -- Chapter 3 Exosome RNAs as biomarkers for cancer therapy -- 3.1 Introduction -- 3.2 Exosomes in cancer -- 3.3 Exosomes from body fluids -- 3.3.1 Resistance to cancer therapeutics -- 3.3.2 Nanodiagnostic exosomes by electrochemical biosensing -- 3.3.3 Characterization of salivary exosomes -- 3.4 Exosomes derived from tumor cells -- 3.4.1 Role of exosomes in metastasis of cancer cells
|
| 505 |
8 |
|
|a 3.4.2 State of exosomes within the enlargement of cancer tissue amidst angiogenesis -- 3.5 Exosomes-Role in maintaining a strategic distance from an assault from immune cells -- 3.6 Potential benefits of exosomal RNAs in malignant growth diagnostics and treatment -- 3.6.1 Exosomal ncRNAs as malignancy indicative biomarkers -- 3.6.2 Uses of exosomal noncoding RNAs (ncRNAs) as cancer therapeutics -- 3.7 Conclusion -- References -- Chapter 4 Tumoral delivery of nanotherapeutics -- 4.1 Introduction -- 4.2 Therapeutics employed for tumor treatment -- 4.2.1 Chemotherapy -- 4.2.2 Genetic material
|
| 505 |
8 |
|
|a 4.2.3 Photodynamic therapy (PDT) -- 4.2.4 Photothermal therapy (PTT) -- 4.2.5 Immunotherapy -- 4.2.6 Sonodynamic therapy -- 4.3 Barriers to tumoral delivery of nanotherapeutics -- 4.3.1 Barriers in the systemic circulation -- 4.3.2 Barriers in the tumor microenvironment -- 4.3.3 Barriers at cellular level -- 4.3.4 Heterogeneity in vascular density among different tumors -- 4.4 Potential of nanocarriers for tumoral delivery of therapeutics -- 4.4.1 Chemotherapy -- 4.4.2 Gene therapy -- 4.4.3 PDT -- 4.4.4 PTT -- 4.4.5 Combination therapy -- 4.4.6 Targeted therapy -- 4.4.6.1 Passive targeting
|
| 500 |
|
|
|a 4.4.6.2 Active targeting.
|
| 500 |
|
|
|a Includes index.
|
| 650 |
|
0 |
|a Biomedical materials.
|
| 650 |
|
0 |
|a Nanostructured materials.
|
| 650 |
|
0 |
|a Nanobiotechnology.
|
| 650 |
|
2 |
|a Nanostructures
|0 (DNLM)D049329
|
| 650 |
|
6 |
|a Biomat�eriaux.
|0 (CaQQLa)201-0025723
|
| 650 |
|
6 |
|a Nanomat�eriaux.
|0 (CaQQLa)201-0258061
|
| 650 |
|
6 |
|a Nanobiotechnologie.
|0 (CaQQLa)000286131
|
| 650 |
|
7 |
|a Biomedical materials.
|2 fast
|0 (OCoLC)fst00832586
|
| 650 |
|
7 |
|a Nanobiotechnology.
|2 fast
|0 (OCoLC)fst01894713
|
| 650 |
|
7 |
|a Nanostructured materials.
|2 fast
|0 (OCoLC)fst01032630
|
| 655 |
|
2 |
|a Handbook
|0 (DNLM)D020479
|
| 655 |
|
7 |
|a Handbooks and manuals.
|2 fast
|0 (OCoLC)fst01423877
|
| 655 |
|
7 |
|a Handbooks and manuals.
|2 lcgft
|
| 655 |
|
7 |
|a Guides et manuels.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001065
|
| 700 |
1 |
|
|a Anand, Krishnan.
|
| 700 |
1 |
|
|a Saravanan, Muthupandian,
|d 1977-
|
| 700 |
1 |
|
|a Chandrasekaran, Balakumar.
|
| 700 |
1 |
|
|a Kanchi, Suvardhan.
|
| 700 |
1 |
|
|a Panchu, Sarojini Jeeva.
|
| 700 |
1 |
|
|a Chen, Quan-Sheng.
|
| 776 |
0 |
8 |
|i Print version:
|a Anand, Krishnan.
|t Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications.
|d San Diego : Elsevier, �2021
|z 9780128210130
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128210130
|z Texto completo
|
